quinpirole has been researched along with carbostyril in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harano, M; Tanaka, M; Yamada, S; Yokoo, H | 1 |
Inoue, A; Kikuchi, T; Miki, S; Misu, Y; Morita, S; Nakata, Y; Seto, M; Ueda, H | 1 |
Bédard, PJ; Britton, DR; Grondin, R; Shiosaki, K | 1 |
Jackson, M; Jenner, P; Treseder, SA | 1 |
Mailman, RB; Urban, JD; Vargas, GA; von Zastrow, M | 1 |
Hashioka, S; Horikawa, H; Iwaki, T; Kanba, S; Kato, T; Mizoguchi, Y; Monji, A; Seki, Y; Suzuki, SO | 1 |
Abe, M; Egashira, N; Fujiwara, M; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Oishi, R; Okuno, R | 1 |
Charntikov, S; Crawford, CA; Der-Ghazarian, T; McDougall, SA; Varela, FA | 1 |
De Carolis, L; Milella, MS; Nencini, P; Schepisi, C | 1 |
Lowry, JP; O'Connor, JJ | 1 |
10 other study(ies) available for quinpirole and carbostyril
Article | Year |
---|---|
Antagonistic effects of OPC-14597, a novel antipsychotic drug, on quinpirole- and (-)-sulpiride-induced changes in evoked dopamine release in rat striatal slices.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Dopamine; Dopamine Agents; Electric Stimulation; In Vitro Techniques; Male; Neostriatum; Piperazines; Quinolones; Quinpirole; Rats; Rats, Wistar; Sulpiride | 1997 |
Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Dopamine Agonists; GTP Phosphohydrolases; Haloperidol; Male; Membranes; Neostriatum; Oligonucleotides, Antisense; Piperazines; Quinolones; Quinpirole; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Up-Regulation | 1997 |
Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Quinolones; Quinpirole; Receptors, Dopamine D1; Thiophenes | 1997 |
The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Callithrix; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hydrazines; Levodopa; Male; Motor Activity; Quinolones; Quinpirole; Thiophenes; Tyrosine | 2000 |
Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways.
Topics: Analysis of Variance; Animals; Arachidonic Acid; Aripiprazole; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Guanosine Triphosphate; Mitogen-Activated Protein Kinases; Piperazines; Quinolones; Quinpirole; Receptors, Dopamine D2; Signal Transduction | 2007 |
Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Brain; Calcium; Cell Survival; Cells, Cultured; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Interferon-gamma; Mice; Microglia; Neurons; Nitric Oxide; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tumor Necrosis Factor-alpha | 2008 |
Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Catalepsy; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Indoles; Ketanserin; Male; Mice; Mice, Inbred ICR; Olanzapine; Piperazines; Piperidines; Postural Balance; Psychomotor Performance; Pyridines; Quinolones; Quinpirole; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists | 2008 |
Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
Topics: Aging; Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Autoreceptors; Brain Chemistry; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Drug Interactions; Female; Haloperidol; Male; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2010 |
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Clomipramine; Compulsive Behavior; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drinking Behavior; Haloperidol; Male; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley | 2011 |
A comparison of the effects of the dopamine partial agonists aripiprazole and (-)-3-PPP with quinpirole on stimulated dopamine release in the rat striatum: Studies using fast cyclic voltammetry in vitro.
Topics: Animals; Aripiprazole; Corpus Striatum; Dopamine; Dopamine Agonists; Drug Partial Agonism; In Vitro Techniques; Male; Piperazines; Piperidines; Quinolones; Quinpirole; Rats; Rats, Wistar | 2012 |